Transition Bio
Cambridge
About Transition Bio
Transition Bio provides condensate technology for drug discovery and diagnostics. The company focuses on the discovery, analysis, and modulation of biological condensates, propelled by a differentiated technological capability that generates expansive drug development opportunities in a hypothesis-free manner.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $63.3M
- Last round: Series Unknown (Oct 2024)
- Website: transitionbio.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/transition-bio-49141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.